When it Comes to Wine, Weird is the New Normal – and That’s For the Better

Two telling things happened in spring 2008: In March, JP Morgan acquired Bear Stearns for $2 per share, to stabilize a Wall Street giant, and about a month later, a cohort of wine collectors gathered at Cru restaurant in New York for an auction that marked those swaggery days. Laurent Ponsot, proprietor of Domaine Ponsot, one of Burgundy’s most important domaines, appeared at Cru and stopped the sale of bottles from his property, claiming among other things a bottle of 1929 Clos de la Roche was fake, as the domaine didn’t produce the wine until 1934.

Read more at the Washington Post.

Follow us on social media for the latest updates in B2B!

Latest

BioTech Startups Want to Revive Failed Medicines to Create New Lifesaving Treatments
Behind the Clinical Trials for Non-Alcohol Fatty Liver Disease that Can Benefit 30% of Americans
July 1, 2022
  The Impact Research Institute (IRI) is Waco, Texas’ resource for extending care options for NAFLD (non-alcohol fatty liver disease.) Nadege Gunn is IRI’s Medical Director and President. She Read more
FABTECH Show Kickoff and Overview of Solutions Distributed by DeGeest
June 30, 2022
This is another episode of Manufacturing A Stronger Standard live from FABTECH 2021. Host and President of LestaUSA and DeGeest Corp., Derek DeGeest, talked with Brad Ruppert, Engineering Manager, and Read more
Improving Quality and Bottomline for Finishing Operations
June 30, 2022
This is another episode of Manufacturing A Stronger Standard from FABTECH 2021. Host and President of Lesta USA and Degeest Corp., Derek Degeest, talked with Bill Robinson, President and Kris Bonnegent, Regional Read more